Byung Chul Jin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Byung Chul Jin has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Sang Wook Kim
Department of Internal Medicine, Research Institute of Clinical Medicine of Jeonbuk National University, Jeonju 54907, Republic of Korea
5 shared publications - Geom Seog Seo
Department of Internal Medicine and Digestive Disease Research Institute, Wonkwang University School of Medicine, Iksan, Korea
4 shared publications - Hyo-Yeop Song
Department of Internal Medicine, Digestive Diseases Research Institute, School of Medicine, Wonkwang University, Iksan 54538, Republic of Korea
4 shared publications - Jun Lee
Department of Internal Medicine, Chosun University College of Medicine, Gwangju, Korea
4 shared publications - Young-Eun Joo
Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea
4 shared publications - Dae-Seong Myung
Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea
3 shared publications
Latest Publications
- Open Access
- 25 October 2026
- Published by The Korean Society of Gastroenterology in The Korean Journal of Gastroenterology
- Vol. 86 (4) , 483-485
Report on the UEG Summer School 2026: Hands-on Training in European Gastroenterology and Its Implications for Training in Korea
Byung Chul Jin and Jung Hyun Noh. Korean J Gastroenterol 2026;86:483-5. https://doi.org/10.4166/kjg.2026.105
- 25 October 2026
- Published by The Korean Society of Gastroenterology in The Korean Journal of Gastroenterology
- Vol. 86 (4) , 483-485
Open AccessReport on the UEG Summer School 2026: Hands-on Training in European Gastroenterology and Its Implications for Training in Korea
Byung Chul Jin and Jung Hyun Noh. Korean J Gastroenterol 2026;86:483-5. https://doi.org/10.4166/kjg.2026.105
- Open Access
- 16 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (3) , e47197
Recurrent gastric variceal bleeding due to wandering spleen – complete resolution following laparoscopic splenectomy: A case report
Background: Wandering spleen is a rare clinical entity caused by laxity or absence of splenic suspensory ligaments, predisposing to torsion of the vascular pedicle and subsequent vascular compromise. In unusual cases, splenic vein torsion may lead to left-sided (sinistral) portal hypertension with isolated gastric varices in the absence of cirrhosis. Although uncommon, variceal bleeding from this mechanism can be severe and requires timely recognition. Case presentation: We report a 56-year-old man who presented with recurrent melena. Esophagogastroduodenoscopy revealed large fundic gastric varices without esophageal varices, and cross-sectional imaging identified a wandering spleen displaced into the pelvic cavity with venous congestion but no evidence of liver disease. Endoscopic cyanoacrylate injection provided temporary hemostasis; however, because of persistent vascular compromise and risk of rebleeding, laparoscopic splenectomy was performed. The postoperative course was uneventful, and follow-up computed tomography 5 months later confirmed complete resolution of perigastric varices and splenic venous congestion, demonstrating the reversibility of sinistral portal hypertension once splenic outflow obstruction is corrected. Conclusion: Wandering spleen with splenic vein torsion should be considered in patients presenting with isolated gastric varices and no signs of liver cirrhosis. While endoscopic therapy may achieve transient hemostasis, it does not correct the underlying hemodynamic disturbance. Splenectomy represents the definitive treatment, achieving durable hemodynamic correction and preventing further bleeding. Early recognition and surgical management are therefore essential for optimal outcomes in this rare but clinically significant condition.
- 16 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (3) , e47197
Open AccessRecurrent gastric variceal bleeding due to wandering spleen – complete resolution following laparoscopic splenectomy: A case report
Background: Wandering spleen is a rare clinical entity caused by laxity or absence of splenic suspensory ligaments, predisposing to torsion of the vascular pedicle and subsequent vascular compromise. In unusual cases, splenic vein torsion may lead to left-sided (sinistral) portal hypertension with isolated gastric varices in the absence of cirrhosis. Although uncommon, variceal bleeding from this mechanism can be severe and requires timely recognition. Case presentation: We report a 56-year-old man who presented with recurrent melena. Esophagogastroduodenoscopy revealed large fundic gastric varices without esophageal varices, and cross-sectional imaging identified a wandering spleen displaced into the pelvic cavity with venous congestion but no evidence of liver disease. Endoscopic cyanoacrylate injection provided temporary hemostasis; however, because of persistent vascular compromise and risk of rebleeding, laparoscopic splenectomy was performed. The postoperative course was uneventful, and follow-up computed tomography 5 months later confirmed complete resolution of perigastric varices and splenic venous congestion, demonstrating the reversibility of sinistral portal hypertension once splenic outflow obstruction is corrected. Conclusion: Wandering spleen with splenic vein torsion should be considered in patients presenting with isolated gastric varices and no signs of liver cirrhosis. While endoscopic therapy may achieve transient hemostasis, it does not correct the underlying hemodynamic disturbance. Splenectomy represents the definitive treatment, achieving durable hemodynamic correction and preventing further bleeding. Early recognition and surgical management are therefore essential for optimal outcomes in this rare but clinically significant condition.
- Open Access
- 10 December 2025
- Published by Korean College of Helicobacter and Upper Gastrointestinal Research in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Vol. 25 (4) , 319-326
Anatomical Alterations and Endoscopic Strategies After Upper Gastrointestinal Surgery
With the increasing number of upper gastrointestinal (GI) surgeries, the anatomical changes resulting from these procedures have become diverse and complex, presenting significant challenges for endoscopic evaluation and intervention. This review systematically analyzes the representative anatomical alterations following upper GI surgeries, including esophageal, gastric, and bariatric surgeries, and proposes effective endoscopic approaches tailored to each surgical type. In esophageal surgery, strategies for evaluating structural changes, such as conduit reconstruction, anastomotic strictures, and delayed gastric emptying, are reviewed. Anatomical alterations associated with various reconstruction methods (Billroth I, Billroth II, Roux-en-Y, and double-tract reconstruction), including anastomotic strictures, bile reflux, and remnant gastric dilatation, are discussed, along with detailed approaches for endoscopic access and assessment. Additionally, we address the significant increase in bariatric surgeries (sleeve gastrectomy and Roux-en-Y gastric bypass) in South Korea and discuss the endoscopic management of related complications, such as marginal ulcers, strictures, and gastrogastric fistulae. Through this review, we emphasize that a thorough understanding of surgery-specific anatomical characteristics, meticulous pre- and post-operative reviews of medical records and imaging, and adherence to the recently highlighted “3C principles” (confirm anatomy, check perfusion, and control complications) are essential for enhancing the accuracy and safety of endoscopic diagnoses and interventions in patients with surgically altered anatomy.
- 10 December 2025
- Published by Korean College of Helicobacter and Upper Gastrointestinal Research in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Vol. 25 (4) , 319-326
Open AccessAnatomical Alterations and Endoscopic Strategies After Upper Gastrointestinal Surgery
With the increasing number of upper gastrointestinal (GI) surgeries, the anatomical changes resulting from these procedures have become diverse and complex, presenting significant challenges for endoscopic evaluation and intervention. This review systematically analyzes the representative anatomical alterations following upper GI surgeries, including esophageal, gastric, and bariatric surgeries, and proposes effective endoscopic approaches tailored to each surgical type. In esophageal surgery, strategies for evaluating structural changes, such as conduit reconstruction, anastomotic strictures, and delayed gastric emptying, are reviewed. Anatomical alterations associated with various reconstruction methods (Billroth I, Billroth II, Roux-en-Y, and double-tract reconstruction), including anastomotic strictures, bile reflux, and remnant gastric dilatation, are discussed, along with detailed approaches for endoscopic access and assessment. Additionally, we address the significant increase in bariatric surgeries (sleeve gastrectomy and Roux-en-Y gastric bypass) in South Korea and discuss the endoscopic management of related complications, such as marginal ulcers, strictures, and gastrogastric fistulae. Through this review, we emphasize that a thorough understanding of surgery-specific anatomical characteristics, meticulous pre- and post-operative reviews of medical records and imaging, and adherence to the recently highlighted “3C principles” (confirm anatomy, check perfusion, and control complications) are essential for enhancing the accuracy and safety of endoscopic diagnoses and interventions in patients with surgically altered anatomy.
- Open Access
- 8 July 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (13) , 1459
The Outcomes of Colorectal Endoscopic Submucosal Dissection in Patients with Chronic Kidney Disease: A Honam Association for the Study of Intestinal Disease (HASID) Multicenter Study
Colorectal neoplasms are prevalent in patients with chronic kidney disease (CKD); however, the safety and efficacy of colorectal endoscopic submucosal dissection (ESD) are not well understood. This retrospective analysis included ESD procedures performed in 1266 patients with CKD across five tertiary medical institutions from January 2015 to December 2020. Patients were categorized based on their estimated glomerular filtration rate (eGFR), which ranged from CKD1 to CKD5 (including those on dialysis). We found that en bloc resection rates remained high across all CKD stages, affirming the procedural efficacy of ESD. Notably, the prevalence of cardiovascular comorbidities, such as ischemic heart disease and diabetes mellitus, significantly increased with an advancing CKD stage, with a corresponding increase in the Charlson Comorbidity Index, highlighting the complexity of managing these patients. Despite these challenges, the complete resection rate was lower in the CKD5 group (50%) than in the CKD1 group (83.4%); however, procedural complications, such as perforation and bleeding, did not significantly differ among the groups. The predictive models for complete resection and major complications showed no significant changes with a decreasing eGFR. These findings underscore that ESD is a feasible and safe treatment for colorectal neoplasms in patients with CKD, successfully balancing the inherent procedural risks with clinical benefits.
- 8 July 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (13) , 1459
Open AccessThe Outcomes of Colorectal Endoscopic Submucosal Dissection in Patients with Chronic Kidney Disease: A Honam Association for the Study of Intestinal Disease (HASID) Multicenter Study
Colorectal neoplasms are prevalent in patients with chronic kidney disease (CKD); however, the safety and efficacy of colorectal endoscopic submucosal dissection (ESD) are not well understood. This retrospective analysis included ESD procedures performed in 1266 patients with CKD across five tertiary medical institutions from January 2015 to December 2020. Patients were categorized based on their estimated glomerular filtration rate (eGFR), which ranged from CKD1 to CKD5 (including those on dialysis). We found that en bloc resection rates remained high across all CKD stages, affirming the procedural efficacy of ESD. Notably, the prevalence of cardiovascular comorbidities, such as ischemic heart disease and diabetes mellitus, significantly increased with an advancing CKD stage, with a corresponding increase in the Charlson Comorbidity Index, highlighting the complexity of managing these patients. Despite these challenges, the complete resection rate was lower in the CKD5 group (50%) than in the CKD1 group (83.4%); however, procedural complications, such as perforation and bleeding, did not significantly differ among the groups. The predictive models for complete resection and major complications showed no significant changes with a decreasing eGFR. These findings underscore that ESD is a feasible and safe treatment for colorectal neoplasms in patients with CKD, successfully balancing the inherent procedural risks with clinical benefits.
- Open Access
- 4 July 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (13) , 3932
Risk Factors for Post-Endoscopic Submucosal Dissection Electrocoagulation Syndrome in Patients with Colorectal Neoplasms: A Multicenter, Large-Scale, Retrospective Cohort Study by the Honam Association for the Study of Intestinal Disease (HASID)
Background and Objectives: Colorectal endoscopic submucosal dissection (ESD) is an effective technique for removing colorectal neoplasms with large or cancerous lesions. However, there are few studies on post-ESD electrocoagulation syndrome (PECS), a complication of colorectal ESD. Therefore, this study aimed to investigate the various risk factors for PECS after colorectal ESD. Materials and Methods: We retrospectively analyzed the medical records of 1413 lesions from 1408 patients who underwent colorectal ESD at five tertiary hospitals between January 2015 and December 2020. We investigated the incidence and risk factors associated with PECS. Based on the data, we developed a risk-scoring model to predict the risk of PECS after colorectal ESD. Results: The incidence rate of PECS was 2.6% (37 patients). In multivariate analysis, the use of anti-platelet agents (odds ratio (OR), 2.474; 95% confidence interval (CI), 1.088–5.626; p < 0.031), a lesion larger than 6 cm (OR 3.755; 95% CI, 1.237–11.395; p = 0.028), a deep submucosal invasion (OR 2.579; 95% CI, 1.022–6.507; p = 0.045), and an ESD procedure time ≥ 60 min (OR 2.691; 95% CI, 1.302–5.560; p = 0.008) were independent risk factors of PECS after colorectal ESD. We developed a scoring model for predicting PECS using these four factors. As the score increased, the incidence of PECS also increased, from 1.3% to 16.6%. PECS occurred more frequently in the high-risk group (≥2) (1.8% vs. 12.4%, p < 0.001). Conclusions: In this study, the risk factors for PECS after colorectal ESD were the use of anti-platelet agents, a lesion larger than 6 cm, a deep submucosal invasion, and an ESD procedure time ≥ 60 min. The risk-scoring model developed in this study using these factors could be effective in predicting and preventing PECS.
- 4 July 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (13) , 3932
Open AccessRisk Factors for Post-Endoscopic Submucosal Dissection Electrocoagulation Syndrome in Patients with Colorectal Neoplasms: A Multicenter, Large-Scale, Retrospective Cohort Study by the Honam Association for the Study of Intestinal Disease (HASID)
Background and Objectives: Colorectal endoscopic submucosal dissection (ESD) is an effective technique for removing colorectal neoplasms with large or cancerous lesions. However, there are few studies on post-ESD electrocoagulation syndrome (PECS), a complication of colorectal ESD. Therefore, this study aimed to investigate the various risk factors for PECS after colorectal ESD. Materials and Methods: We retrospectively analyzed the medical records of 1413 lesions from 1408 patients who underwent colorectal ESD at five tertiary hospitals between January 2015 and December 2020. We investigated the incidence and risk factors associated with PECS. Based on the data, we developed a risk-scoring model to predict the risk of PECS after colorectal ESD. Results: The incidence rate of PECS was 2.6% (37 patients). In multivariate analysis, the use of anti-platelet agents (odds ratio (OR), 2.474; 95% confidence interval (CI), 1.088–5.626; p < 0.031), a lesion larger than 6 cm (OR 3.755; 95% CI, 1.237–11.395; p = 0.028), a deep submucosal invasion (OR 2.579; 95% CI, 1.022–6.507; p = 0.045), and an ESD procedure time ≥ 60 min (OR 2.691; 95% CI, 1.302–5.560; p = 0.008) were independent risk factors of PECS after colorectal ESD. We developed a scoring model for predicting PECS using these four factors. As the score increased, the incidence of PECS also increased, from 1.3% to 16.6%. PECS occurred more frequently in the high-risk group (≥2) (1.8% vs. 12.4%, p < 0.001). Conclusions: In this study, the risk factors for PECS after colorectal ESD were the use of anti-platelet agents, a lesion larger than 6 cm, a deep submucosal invasion, and an ESD procedure time ≥ 60 min. The risk-scoring model developed in this study using these factors could be effective in predicting and preventing PECS.
- Open Access
- 26 April 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (17) , e37936
Predictive factors associated with technical difficulty in colorectal endoscopic submucosal dissection: A Honam Association for the Study of Intestinal Disease (HASID) multicenter study
Colorectal endoscopic submucosal dissection (ESD) is a promising but challenging procedure. It is not widely performed due to its technical difficulty. We aimed to find the predictive factors associated with technical difficulty in colorectal ESD before the procedure. Clinical data from patients who underwent ESD for colorectal tumors in 5 hospitals in Honam province of South Korea between 2015 and 2020 were reviewed retrospectively. Technically difficult colorectal ESD procedure was defined in 3 points. Long procedure time (longer than 60 minutes), occurrence of perforation, and failure of en bloc resection. Factors associated with technically difficult ESD were included as main outcome measure. 1446 patients were identified and their data were analyzed. Median procedure time was 30.0 minutes and median long axis of the tumor was 20.1 mm. Technically difficult procedures including long procedure time were 231 cases (16.0%), perforation occurred in 34 cases (2.3%), and en bloc resection was done in 1292 cases (89.3%). Tumor size larger than 35 mm (odd ratio [OR]: 1.474, P = .047), central depression or ulceration in the lesion (OR: 1.474, P = .013), previous endoscopic mucosal resection (EMR) or polypectomy procedure (OR: 2.428, P = .020) were associated with technically difficult ESD. Descending colon-located tumor (OR: 5.355, P < .001), and use of IT knife (OR: 4.157, P = .003) were associated with perforation. Recognizing factors associated with technically difficult ESD can help in planning the ESD procedure beforehand.
- 26 April 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (17) , e37936
Open AccessPredictive factors associated with technical difficulty in colorectal endoscopic submucosal dissection: A Honam Association for the Study of Intestinal Disease (HASID) multicenter study
Colorectal endoscopic submucosal dissection (ESD) is a promising but challenging procedure. It is not widely performed due to its technical difficulty. We aimed to find the predictive factors associated with technical difficulty in colorectal ESD before the procedure. Clinical data from patients who underwent ESD for colorectal tumors in 5 hospitals in Honam province of South Korea between 2015 and 2020 were reviewed retrospectively. Technically difficult colorectal ESD procedure was defined in 3 points. Long procedure time (longer than 60 minutes), occurrence of perforation, and failure of en bloc resection. Factors associated with technically difficult ESD were included as main outcome measure. 1446 patients were identified and their data were analyzed. Median procedure time was 30.0 minutes and median long axis of the tumor was 20.1 mm. Technically difficult procedures including long procedure time were 231 cases (16.0%), perforation occurred in 34 cases (2.3%), and en bloc resection was done in 1292 cases (89.3%). Tumor size larger than 35 mm (odd ratio [OR]: 1.474, P = .047), central depression or ulceration in the lesion (OR: 1.474, P = .013), previous endoscopic mucosal resection (EMR) or polypectomy procedure (OR: 2.428, P = .020) were associated with technically difficult ESD. Descending colon-located tumor (OR: 5.355, P < .001), and use of IT knife (OR: 4.157, P = .003) were associated with perforation. Recognizing factors associated with technically difficult ESD can help in planning the ESD procedure beforehand.
- Open Access
- 9 January 2024
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 56 (S 01) , E234-E235
Rare case of beet juice mimicking gastrointestinal bleeding: diagnostic implication
Lower gastrointestinal hemorrhage has demonstrated an increasing trend in morbidity and mortality, classifying it as a potential cause of life-threatening events [1]. In cases of acute intestinal bleeding in the large intestine, a colonoscopy should be performed when the patient is stable to identify the cause. This case highlights the importance of comprehensive patient interviews before diagnostic procedures. A 68-year-old man with a history of chronic constipation was taking mosapride and magnesium hydroxide. He had no other significant medical history and underwent a screening colonoscopy. The patient was hospitalized for diverticulitis 10 years ago and underwent a hemorrhoidectomy 6 years ago. At the last colonoscopy 2 years ago, several diverticula were observed in the ascending colon, and one hyperplastic polyp was also removed. For bowel preparation, the patient used a split-dosing regimen of 2-L low-dose polyethylene glycol, specifically Cleanblueall powder, and reported no stool abnormalities during preparation. On the morning of the test, the patient called to ask if it was permissible to consume electrolyte drinks and received positive advice from the nurse. Lower gastrointestinal bleeding was suspected; a colonoscopy was performed that morning [2]. Multiple fresh and red diverticula were visualized in the ascending colon, despite being mixed with normal stool ([Fig. 1], [Fig. 2], [Fig. 3]). Yellow fluid was observed in the descending colon and sigmoid colon ([Fig. 4], [Fig. 5]); no bleeding areas were identified ([Video 1]). Thereafter, blood pressure stabilized at 120/70 mmHg, pulse rate stabilized at 70 bpm, and the patient appeared comfortable. The patient later mentioned consuming mixed beets before the morning colonoscopy, mistaking them for a commercial electrolyte drink, to rehydrate and replenish electrolytes. A 1-day observation revealed red fluid in the stool without any signs of active bleeding. This case highlights the possibility of misinterpreting beet consumption as gastrointestinal bleeding due to their similar color to blood. Endoscopy_UCTN_Code_TTT_1AQ_2AZ Article published online: 08 March 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 9 January 2024
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 56 (S 01) , E234-E235
Open AccessRare case of beet juice mimicking gastrointestinal bleeding: diagnostic implication
Lower gastrointestinal hemorrhage has demonstrated an increasing trend in morbidity and mortality, classifying it as a potential cause of life-threatening events [1]. In cases of acute intestinal bleeding in the large intestine, a colonoscopy should be performed when the patient is stable to identify the cause. This case highlights the importance of comprehensive patient interviews before diagnostic procedures. A 68-year-old man with a history of chronic constipation was taking mosapride and magnesium hydroxide. He had no other significant medical history and underwent a screening colonoscopy. The patient was hospitalized for diverticulitis 10 years ago and underwent a hemorrhoidectomy 6 years ago. At the last colonoscopy 2 years ago, several diverticula were observed in the ascending colon, and one hyperplastic polyp was also removed. For bowel preparation, the patient used a split-dosing regimen of 2-L low-dose polyethylene glycol, specifically Cleanblueall powder, and reported no stool abnormalities during preparation. On the morning of the test, the patient called to ask if it was permissible to consume electrolyte drinks and received positive advice from the nurse. Lower gastrointestinal bleeding was suspected; a colonoscopy was performed that morning [2]. Multiple fresh and red diverticula were visualized in the ascending colon, despite being mixed with normal stool ([Fig. 1], [Fig. 2], [Fig. 3]). Yellow fluid was observed in the descending colon and sigmoid colon ([Fig. 4], [Fig. 5]); no bleeding areas were identified ([Video 1]). Thereafter, blood pressure stabilized at 120/70 mmHg, pulse rate stabilized at 70 bpm, and the patient appeared comfortable. The patient later mentioned consuming mixed beets before the morning colonoscopy, mistaking them for a commercial electrolyte drink, to rehydrate and replenish electrolytes. A 1-day observation revealed red fluid in the stool without any signs of active bleeding. This case highlights the possibility of misinterpreting beet consumption as gastrointestinal bleeding due to their similar color to blood. Endoscopy_UCTN_Code_TTT_1AQ_2AZ Article published online: 08 March 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 10 December 2023
- Published by Korean College of Helicobacter and Upper Gastrointestinal Research in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Vol. 23 (4) , 294-301
Clinical Characteristics of Cytomegalovirus Disease of the Upper Gastrointestinal Tract: A 10-Year Multicenter Retrospective Study
Objectives: Gastrointestinal cytomegalovirus (CMV) disease is a major contributor to mortality in immunocompromised patients. Few studies have discussed upper gastrointestinal CMV (UGICMV) disease in immunocompetent patients. We compared the clinical outcomes of UGI-CMV between immunocompromised and immunocompetent patients.Methods: This retrospective study included patients with UGI-CMV disease from five tertiary hospitals across Korea (2010– 2022). Patients’ clinical data and outcomes were recorded.Results: UGI-CMV was diagnosed in 54 patients; 27 (50.0%) had esophageal, 24 (44.4%) had gastric, and 3 patients (5.6%) had duodenal involvement. Patients’ median age was 64 years (interquartile range 53–75 years), and the most common comorbidities included hypertension (57.4%) and diabetes (38.9%). The predominant symptom was abdominal pain (46.3%), and the most common endoscopic finding was ulcers (70.4%). Antiviral treatment was administered to 31 patients, and 23 patients underwent observation without treatment. We investigated 32 immunocompromised (59.3%) and 22 immunocompetent (40.7%) patients and observed no intergroup differences in comorbidities and in laboratory and endoscopic findings. Immunocompromised patients had longer length of hospitalization (median 46.2 days vs. 20.0 days, p=0.001). However, treatment outcomes, including the need for intensive care unit admission and mortality did not significantly differ. The overall mortality rate was 13.0%; one patient from the immunocompromised group died of UGI-CMV disease. The treatment success rate was higher in immunocompromised patients who received antiviral therapy (p=0.011).Conclusions: UGI-CMV disease is not uncommon in immunocompetent patients, although symptoms are milder than those in immunocompromised patients. Our findings emphasize the importance of clinical vigilance for accurate diagnosis of CMV infection, particularly in susceptible symptomatic patients and highlight the need for active antiviral treatment for management of immunocompromised patients.
- 10 December 2023
- Published by Korean College of Helicobacter and Upper Gastrointestinal Research in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Vol. 23 (4) , 294-301
Open AccessClinical Characteristics of Cytomegalovirus Disease of the Upper Gastrointestinal Tract: A 10-Year Multicenter Retrospective Study
Objectives: Gastrointestinal cytomegalovirus (CMV) disease is a major contributor to mortality in immunocompromised patients. Few studies have discussed upper gastrointestinal CMV (UGICMV) disease in immunocompetent patients. We compared the clinical outcomes of UGI-CMV between immunocompromised and immunocompetent patients.Methods: This retrospective study included patients with UGI-CMV disease from five tertiary hospitals across Korea (2010– 2022). Patients’ clinical data and outcomes were recorded.Results: UGI-CMV was diagnosed in 54 patients; 27 (50.0%) had esophageal, 24 (44.4%) had gastric, and 3 patients (5.6%) had duodenal involvement. Patients’ median age was 64 years (interquartile range 53–75 years), and the most common comorbidities included hypertension (57.4%) and diabetes (38.9%). The predominant symptom was abdominal pain (46.3%), and the most common endoscopic finding was ulcers (70.4%). Antiviral treatment was administered to 31 patients, and 23 patients underwent observation without treatment. We investigated 32 immunocompromised (59.3%) and 22 immunocompetent (40.7%) patients and observed no intergroup differences in comorbidities and in laboratory and endoscopic findings. Immunocompromised patients had longer length of hospitalization (median 46.2 days vs. 20.0 days, p=0.001). However, treatment outcomes, including the need for intensive care unit admission and mortality did not significantly differ. The overall mortality rate was 13.0%; one patient from the immunocompromised group died of UGI-CMV disease. The treatment success rate was higher in immunocompromised patients who received antiviral therapy (p=0.011).Conclusions: UGI-CMV disease is not uncommon in immunocompetent patients, although symptoms are milder than those in immunocompromised patients. Our findings emphasize the importance of clinical vigilance for accurate diagnosis of CMV infection, particularly in susceptible symptomatic patients and highlight the need for active antiviral treatment for management of immunocompromised patients.
- Open Access
- 28 September 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (19) , 6255
Effectiveness and Safety of Endoscopic Submucosal Dissection for Colorectal Neoplasm in Patients with High Charlson Comorbidity Index Score: A HASID Multicenter Study
Endoscopic submucosal dissection (ESD) is an effective method for removing early colorectal lesions. However, research on the safety and efficacy of ESD in patients with various underlying conditions remains limited. This study retrospectively examined ESD outcomes in colorectal neoplasm patients from five tertiary medical centers. The Charlson Comorbidity Index (CCI) and age-adjusted CCI (ACCI) were analyzed, and the differences in complete resection and complication rates were analyzed. The CCI, ACCI, and complication rates tended to gradually increase proportionally, and the complication resection rate increased from CCI 2 to ACCI 4 as the starting point, followed by a decreasing trend. Of these, 140 patients (9.7%) had a CCI score of 3 or higher. The high CCI group was older (70.6% vs. 64.7%, p < 0.01) and had a higher proportion of men (70.7% vs. 58.7%, p < 0.01) than the low CCI group. The high CCI group had a higher incidence of cancer than the low CCI group (77.9% vs. 65.2%, p < 0.01). The en bloc resection rate (90.0% vs. 89.3%, p = 0.79) and complete resection rate (75.7% vs. 81.2%, p = 0.12) were not significantly different between the two groups. Colorectal ESD can be safely and effectively performed in patients with various underlying medical conditions.
- 28 September 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (19) , 6255
Open AccessEffectiveness and Safety of Endoscopic Submucosal Dissection for Colorectal Neoplasm in Patients with High Charlson Comorbidity Index Score: A HASID Multicenter Study
Endoscopic submucosal dissection (ESD) is an effective method for removing early colorectal lesions. However, research on the safety and efficacy of ESD in patients with various underlying conditions remains limited. This study retrospectively examined ESD outcomes in colorectal neoplasm patients from five tertiary medical centers. The Charlson Comorbidity Index (CCI) and age-adjusted CCI (ACCI) were analyzed, and the differences in complete resection and complication rates were analyzed. The CCI, ACCI, and complication rates tended to gradually increase proportionally, and the complication resection rate increased from CCI 2 to ACCI 4 as the starting point, followed by a decreasing trend. Of these, 140 patients (9.7%) had a CCI score of 3 or higher. The high CCI group was older (70.6% vs. 64.7%, p < 0.01) and had a higher proportion of men (70.7% vs. 58.7%, p < 0.01) than the low CCI group. The high CCI group had a higher incidence of cancer than the low CCI group (77.9% vs. 65.2%, p < 0.01). The en bloc resection rate (90.0% vs. 89.3%, p = 0.79) and complete resection rate (75.7% vs. 81.2%, p = 0.12) were not significantly different between the two groups. Colorectal ESD can be safely and effectively performed in patients with various underlying medical conditions.